{
    "abstract": "Posterior urethral valves (PUV) represents a heterogenous spectrum in which guidelines for management are lacking particularly for those patients facing end-stage kidney disease and transplant. In this study we aim to 1) evaluate our long term PUV pediatric transplant outcomes compared to those without lower urinary tract dysfunction and 2) assess our PUV cohort for trends in bladder management and evaluate outcomes to inform development of institutional guidelines.\nA retrospective cohort analysis of all patients with a diagnosis of PUV who underwent kidney transplant from 2000 to 2023 was completed. A matched cohort of patients without lower urinary tract dysfunction was identified for comparison of graft function. Charts of PUV patients were reviewed for both sociodemographic and clinical variables. Patients were classified by bladder management at the time of transplantation into three separate groups for analysis: voiding, clean intermittent catheterization, and incontinent diversion. Primary outcomes of interest were eGFR, graft failure, and UTIs post-transplant.\n45 patients met inclusion criteria. 69% were on dialysis prior to transplant. 51% of grafts were from a deceased donor. Bladder management consisted of voiding (62%), CIC (4 via urethra, 10 via channel) (31%), and incontinent diversion (7%). 20% underwent augmentation cystoplasty (5\u00a0=\u00a0ureter, 2\u00a0=\u00a0gastric, 1\u00a0=\u00a0colon, and 1\u00a0=\u00a0ileum) prior to or at the time of transplant. Median follow up duration was 5.4 years (3.0, 10.8). Patients on CIC had higher rates of UTI; however, we found no significant difference in graft function outcomes (eGFR, graft failure) between bladder management groups or year of transplant. VUR in the transplant kidney was associated with vesicostomy (p\u00a0=\u00a00.028). 2 of 2 gastric augments developed malignancy, one of which was cause of death. Graft failure rate was 22% in both the PUV group and matched cohort, with median interval times to failure of 6.7 years and 3.7 years, respectively (p\u00a0=\u00a00.71). There were no differences in eGFR at follow-up time points between the PUV and matched cohort.\nPatients with PUV represent a spectrum of disease with heterogeneous management before and after kidney transplant. Overall, graft function outcomes were similar when compared to matched cohort without lower urinary tract dysfunction. Patients on CIC had higher rates of UTI but without impact on graft function. Gastric augmentation cystoplasty should be avoided given risk for malignancy. Guidelines to standardize evaluation and management would be helpful for patient care and outcomes.",
    "authors": [
        {
            "affiliation": "Seattle Children's Hospital, Division of Urology, 4800 Sand Point Way NE 98105, United States; University of Washington, Department of Urology, 1959 NE Pacific Street, Seattle, WA 98195, United States. Electronic address: haileysilverii@gmail.com.",
            "firstname": "Hailey",
            "initials": "H",
            "lastname": "Silverii"
        },
        {
            "affiliation": "Seattle Children's Hospital, Division of Urology, 4800 Sand Point Way NE 98105, United States; University of Washington, Department of Urology, 1959 NE Pacific Street, Seattle, WA 98195, United States.",
            "firstname": "Paul",
            "initials": "P",
            "lastname": "Merguerian"
        },
        {
            "affiliation": "Seattle Children's Hospital, Division of Urology, 4800 Sand Point Way NE 98105, United States; University of Washington, Department of Urology, 1959 NE Pacific Street, Seattle, WA 98195, United States.",
            "firstname": "Nicolas",
            "initials": "N",
            "lastname": "Fernandez"
        },
        {
            "affiliation": "Seattle Children's Hospital, Division of Nephrology, 4800 Sand Point Way NE 98105, United States.",
            "firstname": "Jodi",
            "initials": "J",
            "lastname": "Smith"
        },
        {
            "affiliation": "Seattle Children's Hospital, Division of Urology, 4800 Sand Point Way NE 98105, United States; University of Washington, Department of Urology, 1959 NE Pacific Street, Seattle, WA 98195, United States.",
            "firstname": "Margarett",
            "initials": "M",
            "lastname": "Shnorhavorian"
        },
        {
            "affiliation": "Seattle Children's Hospital, Division of Urology, 4800 Sand Point Way NE 98105, United States; University of Washington, Department of Urology, 1959 NE Pacific Street, Seattle, WA 98195, United States.",
            "firstname": "Jennifer",
            "initials": "J",
            "lastname": "Ahn"
        }
    ],
    "conclusions": null,
    "copyrights": "Copyright \u00a9 2024 Journal of Pediatric Urology Company. Published by Elsevier Ltd. All rights reserved.",
    "doi": "10.1016/j.jpurol.2024.06.022",
    "journal": "Journal of pediatric urology",
    "keywords": [
        "Augment",
        "Graft failure",
        "Pediatric kidney transplant",
        "Posterior urethral valves"
    ],
    "methods": null,
    "publication_date": "2024-07-06",
    "pubmed_id": "38969556",
    "results": "45 patients met inclusion criteria. 69% were on dialysis prior to transplant. 51% of grafts were from a deceased donor. Bladder management consisted of voiding (62%), CIC (4 via urethra, 10 via channel) (31%), and incontinent diversion (7%). 20% underwent augmentation cystoplasty (5\u00a0=\u00a0ureter, 2\u00a0=\u00a0gastric, 1\u00a0=\u00a0colon, and 1\u00a0=\u00a0ileum) prior to or at the time of transplant. Median follow up duration was 5.4 years (3.0, 10.8). Patients on CIC had higher rates of UTI; however, we found no significant difference in graft function outcomes (eGFR, graft failure) between bladder management groups or year of transplant. VUR in the transplant kidney was associated with vesicostomy (p\u00a0=\u00a00.028). 2 of 2 gastric augments developed malignancy, one of which was cause of death. Graft failure rate was 22% in both the PUV group and matched cohort, with median interval times to failure of 6.7 years and 3.7 years, respectively (p\u00a0=\u00a00.71). There were no differences in eGFR at follow-up time points between the PUV and matched cohort.",
    "title": "Posterior urethral valves and kidney transplantation: Identifying opportunities for improvement.",
    "xml": "<Element 'PubmedArticle' at 0x788501e5e570>"
}